<?xml version="1.0" encoding="UTF-8" standalone="no"?><document id="DDI-DrugBank.d233">
    <sentence id="DDI-DrugBank.d233.s0" text="Use with Allopurinol: The principal pathway for detoxification of azathioprine is inhibited by allopurinol.">
        <entity charOffset="9-19" id="DDI-DrugBank.d233.s0.e0" text="Allopurinol" type="drug"/>
        <entity charOffset="66-77" id="DDI-DrugBank.d233.s0.e1" text="azathioprine" type="drug"/>
        <entity charOffset="95-105" id="DDI-DrugBank.d233.s0.e2" text="allopurinol" type="drug"/>
        <pair ddi="false" e1="DDI-DrugBank.d233.s0.e0" e2="DDI-DrugBank.d233.s0.e1" id="DDI-DrugBank.d233.s0.p0"/>
        <pair ddi="false" e1="DDI-DrugBank.d233.s0.e0" e2="DDI-DrugBank.d233.s0.e2" id="DDI-DrugBank.d233.s0.p1"/>
        <pair ddi="true" e1="DDI-DrugBank.d233.s0.e1" e2="DDI-DrugBank.d233.s0.e2" id="DDI-DrugBank.d233.s0.p2" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d233.s1" text="Patients receiving azathioprine and allopurinol concomitantly should have a dose reduction of azathioprine, to approximately 1/3 to 1/4 the usual dose.">
        <entity charOffset="19-30" id="DDI-DrugBank.d233.s1.e0" text="azathioprine" type="drug"/>
        <entity charOffset="36-46" id="DDI-DrugBank.d233.s1.e1" text="allopurinol" type="drug"/>
        <entity charOffset="94-105" id="DDI-DrugBank.d233.s1.e2" text="azathioprine" type="drug"/>
        <pair ddi="true" e1="DDI-DrugBank.d233.s1.e0" e2="DDI-DrugBank.d233.s1.e1" id="DDI-DrugBank.d233.s1.p0" type="advise"/>
        <pair ddi="false" e1="DDI-DrugBank.d233.s1.e0" e2="DDI-DrugBank.d233.s1.e2" id="DDI-DrugBank.d233.s1.p1"/>
        <pair ddi="false" e1="DDI-DrugBank.d233.s1.e1" e2="DDI-DrugBank.d233.s1.e2" id="DDI-DrugBank.d233.s1.p2"/>
    </sentence>
    <sentence id="DDI-DrugBank.d233.s2" text="Use with Other Agents Affecting Myelopoesis: Drugs which may affect leukocyte production, including co-trimoxazole, may lead to exaggerated leukopenia, especially in renal transplant recipients.">
        <entity charOffset="100-113" id="DDI-DrugBank.d233.s2.e0" text="co-trimoxazole" type="brand"/>
    </sentence>
    <sentence id="DDI-DrugBank.d233.s3" text="Use with Angiotensln Converting Enzyme Inhibitors: The use of angiotensin converting enzyme inhibitors to control hypertension in patients on azathioprine has been reported to induce severe leukopenia.">
        <entity charOffset="9-48" id="DDI-DrugBank.d233.s3.e0" text="Angiotensln Converting Enzyme Inhibitors" type="group"/>
        <entity charOffset="62-101" id="DDI-DrugBank.d233.s3.e1" text="angiotensin converting enzyme inhibitors" type="group"/>
        <entity charOffset="142-153" id="DDI-DrugBank.d233.s3.e2" text="azathioprine" type="drug"/>
        <pair ddi="false" e1="DDI-DrugBank.d233.s3.e0" e2="DDI-DrugBank.d233.s3.e1" id="DDI-DrugBank.d233.s3.p0"/>
        <pair ddi="false" e1="DDI-DrugBank.d233.s3.e0" e2="DDI-DrugBank.d233.s3.e2" id="DDI-DrugBank.d233.s3.p1"/>
        <pair ddi="true" e1="DDI-DrugBank.d233.s3.e1" e2="DDI-DrugBank.d233.s3.e2" id="DDI-DrugBank.d233.s3.p2" type="effect"/>
    </sentence>
</document>